中文名称：卡比多巴
  • 卡别多巴; (S)-3-(3,4-二羟基苯基)-2-肼基-2-甲基-丙酸
  • S-(-)-carbidopa
  • 1-(Mesithylene-2-sulfonyl)-3-nitro-1,2,4-triazole; 3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methyl-propanoic acid; (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methyl-propanoic acid; (-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid; alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid; alpha-Methyldopahydrazine; Benzenepropanoic acid; alpha-hydrazino-3,4-dihydroxy-alpha-methyl-(S )-; Carbidopa; Carbidopa anhydrous; Carbidopa [USAN:BAN:INN:JAN]; Carbidopum [INN-Latin]; CCRIS 5093; Hadrazino-alpha-methyldopa; alpha-HYDRAZINO-3,4-DIHYDROXY-alpha-METHYL-L-KINSON; 3-(3,4-DIHYDROXY-PHENYL)-2-HYDRAZINO-2-METHYL-PROPIONIC ACID; L-3-(3,4-Dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid; L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid; L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic aci d; L-alpha-Methyldopahydrazine; MK 486; MLS000069628; N-Aminomethyldopa; NCGC00024596-01; S(-)-CARBIDOPA; SMR000058235; Tocris-0455; (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid hydrate (1:1)
  • 28860-95-9
  • 249-271-9
  • CC10H14N2O4
  • 226.231
  • InChI=1/C10H14N2O4.H2O/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6;/h2-4,12-14H,5,11H2,1H3,(H,15,16);1H2/t10-;/m0./s1
  • 卡比多巴 28860-95-9
  • 528.7°C at 760 mmHg
  • 273.5°C
  • 5.27E-12mmHg at 25°C
  • 用于各种原因引起的帕金森症。